Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients

References

• Agúndez, J.A., et al., 2001. Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients. Oncology, 61(1), 59–63.
   PubMed Web of Science ®Google Scholar
• Aklillu, E., et al., 2002. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population. Molecular pharmacology, 61(3), 586–594.
   PubMed Web of Science ®Google Scholar
• Arand, M., et al., 1996. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical biochemistry, 236(1), 184–186.
   PubMed Web of Science ®Google Scholar
• Argiris, A., et al., 2008. Head and neck cancer. Lancet (London, England), 371(9625), 1695–1709.
   PubMed Web of Science ®Google Scholar
• Ariyoshi, N., et al., 2000. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6* 1B) apparently diagnosed as heterozygotes of CYP2A6* 1A and CYP2A6* 4 C. Pharmacogenetics and genomics, 10(8), 687–693.
   Google Scholar
• Beà, S., et al., 2001. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer research, 61, 2409–2412.
   PubMed Web of Science ®Google Scholar
• Butkiewicz, D., et al., 1999. GSTMI, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. European journal of cancer prevention, 8(4), 315–324.
   PubMed Web of Science ®Google Scholar
• Cascorbi, I., Brockmöller, J., and Roots, I., 1996. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer research, 56, 4965–4969.
   PubMed Web of Science ®Google Scholar
• Chen, R.-J., et al., 2011. Epigenetic effects and molecular mechanisms of tumorigenesis induced by cigarette smoke: an overview. Journal of oncology, 2011, 654931.
   PubMedGoogle Scholar
• Choi, P. and Chen, C., 2005. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer, 104(6), 1113–1128.
   PubMed Web of Science ®Google Scholar
• Cortesina, G. and Martone, T., 2006. Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature. Acta otorhinolaryngologica italica, 26, 317.
   PubMedGoogle Scholar
• Dey, A., et al., 2006. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes. Life sciences, 79(18), 1729–1735.
   PubMed Web of Science ®Google Scholar
• Einspahr, J.G., et al., 2003. Association between cyclooxygenase expression and colorectal adenoma characteristics. Cancer research, 63, 3891–3893.
   PubMed Web of Science ®Google Scholar
• Enoch, S. and Cronin, M., 2010. A review of the electrophilic reaction chemistry involved in covalent DNA binding. Critical reviews in toxicology, 40(8), 728–748.
   PubMed Web of Science ®Google Scholar
• Farnebo, L., et al., 2013. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. International journal of cancer, 133(8), 1994–2003.
   PubMed Web of Science ®Google Scholar
• Furukawa, M., et al., 2004. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer science, 95(6), 520–529.
   PubMed Web of Science ®Google Scholar
• Gomez, A., et al., 2007. Expression of CYP2W1 in colon tumors: regulation by gene methylation. Pharmacogenomics, 8(10), 1315–1325.
   PubMed Web of Science ®Google Scholar
• Grau, J.J., et al., 2007. Expression of cyclooxygenase-2 mRNA in peripheral blood of head and neck cancer patients and in healthy controls. A pilot study. Acta oto-laryngologica, 127(1), 71–75.
   PubMed Web of Science ®Google Scholar
• Harries, L.W., et al., 1997. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18(4), 641–644.
   PubMed Web of Science ®Google Scholar
• Hashibe, M., et al., 2009. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer epidemiology biomarkers & prevention, 18, 541–550.
   PubMed Web of Science ®Google Scholar
• Hayes, J.D., Flanagan, J.U., and Jowsey, I.R., 2005. Glutathione transferases. Annual review of pharmacology and toxicology, 45, 51–88.
   PubMed Web of Science ®Google Scholar
• Ho, Y.-S., et al., 2005. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFκB activation and cyclin D1 up-regulation. Toxicology and applied pharmacology, 205(2), 133–148.
   PubMed Web of Science ®Google Scholar
• Hong, D.-Y., et al., 2009. Expression of VEGF, HGF, IL-6, IL-8, MMP-9, telomerase in peripheral blood of patients with head and neck squamous cell carcinoma. Clinical and experimental otorhinolaryngology, 2(4), 186.
   PubMed Web of Science ®Google Scholar
• Ikeguchi, M. and Kaibara, N., 2002. Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. British journal of cancer, 87(8), 883.
   PubMed Web of Science ®Google Scholar
• Kelders, W., et al., 2002. The association between glutathione S-transferase P1 genotype and plasma level in head and neck cancer. The laryngoscope, 112(3), 462–466.
   PubMed Web of Science ®Google Scholar
• Kisselev, P., et al., 2005. Association of CYP1A1 polymorphisms with differential metabolic activation of 17β-estradiol and estrone. Cancer research, 65(7), 2972–2978.
   PubMed Web of Science ®Google Scholar
• Koch, F., et al., 2010. Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma. Oral oncology, 46(2), 128–133.
   PubMed Web of Science ®Google Scholar
• Leemans, C.R., Braakhuis, B.J., and Brakenhoff, R.H., 2011. The molecular biology of head and neck cancer. Nature reviews. Cancer, 11(1), 9.
   PubMed Web of Science ®Google Scholar
• Liu, S., et al., 2001. Elucidation of CYP2E1 5ncbi.nlm.nih.RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral oncology, 37(5), 437–445.
   PubMed Web of Science ®Google Scholar
• Löfstedt, T., et al., 2004. Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. Journal of biological chemistry, 279(38), 39223–39231
   PubMed Web of Science ®Google Scholar
• Martinez, J.M., et al., 2002. Differential toxicogenomic responses to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells. Toxicological sciences, 69(2), 409–423.
   PubMed Web of Science ®Google Scholar
• Masood, N. and Kayani, M.A., 2013. Expression patterns of carcinogen detoxifying genes (CYP1A1, GSTP1 & GSTT1) in HNC patients. Pathology & oncology research, 19, 89–94.
   PubMed Web of Science ®Google Scholar
• Maurya, S.S., et al., 2014. Polymorphisms in drug‐metabolizing enzymes and risk to head and neck cancer: evidence for gene–gene and gene–environment interaction. Environmental and molecular mutagenesis, 55(2), 134–144.
   PubMed Web of Science ®Google Scholar
• Mcfadyen, M.C., Melvin, W.T., and Murray, G.I., 2004. Cytochrome P450 enzymes: novel options for cancer therapeutics. Molecular cancer therapeutics, 3, 363–371.
   PubMed Web of Science ®Google Scholar
• Medici, D., Hay, E.D., and Olsen, B.R., 2008. Snail and Slug promote epithelial-mesenchymal transition through β-catenin–T-cell factor-4-dependent expression of transforming growth factor-β3. Molecular biology of the cell, 19(11), 4875–4887.
   PubMed Web of Science ®Google Scholar
• Mohr, S. and Liew, C.-C., 2007. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends in molecular medicine, 13(10), 422–432.
   PubMed Web of Science ®Google Scholar
• Mougiakakos, D., et al., 2011. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood, 117(18), 4826–4835
   PubMed Web of Science ®Google Scholar
• Mwenifumbo, J.C., et al., 2008. Identification of novel CYP2A6* 1B variants: the CYP2A6* 1B allele is associated with faster in vivo nicotine metabolism. Clinical pharmacology & therapeutics, 83, 115–121.
   PubMed Web of Science ®Google Scholar
• Nagini, S., et al., 2009. Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral oncology, 45(6), e31–e37.
   PubMed Web of Science ®Google Scholar
• Nguyen, L.T., et al., 2000. Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays. Drug metabolism and disposition, 28, 987–993.
   PubMed Web of Science ®Google Scholar
• Ophuis, M.B.O., et al., 1998. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma. Cancer, 82(12), 2434–2438.
   PubMed Web of Science ®Google Scholar
• Oyama, T., et al., 2012. Cytochrome p450 in non-small cell lung cancer related to exogenous chemical metabolism. Frontiers in bioscience, 4, 1539–1546.
   Google Scholar
• Pan, G., et al., 1998. A study of multiple biomarkers in coke oven workers – a cross-sectional study in China. Carcinogenesis, 19(11), 1963–1968.
   PubMed Web of Science ®Google Scholar
• Petros, W.P., et al., 2012. Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy, 32(10), 920–931.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Antona, C. and Ingelman-Sundberg, M., 2006. Cytochrome P450 pharmacogenetics and cancer. Oncogene, 25(11), 1679.
   PubMed Web of Science ®Google Scholar
• Rotunno, M., et al., 2012. GSTM1 and GSTT1 copy numbers and mRNA expression in lung cancer. Molecular carcinogenesis, 51(S1), E142–E150.
   PubMedGoogle Scholar
• Ruwali, M., et al., 2009. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors. Environmental and molecular mutagenesis, 50(6), 473–482.
   PubMed Web of Science ®Google Scholar
• Salimi, M., et al., 2012. Change in nicotine-induced VEGF, PGE 2 AND COX-2 expression following COX inhibition in human oral squamous cancer. Journal of environmental pathology, toxicology and oncology, 31(4), 349–356.
   PubMed Web of Science ®Google Scholar
• Sato, M., et al., 2000. Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral oncology, 36(3), 267–271.
   PubMed Web of Science ®Google Scholar
• Saurabh, K., et al., 2010. Polycyclic aromatic hydrocarbon metabolizing cytochrome P450s in freshly prepared uncultured rat blood lymphocytes. Biochemical pharmacology, 79(8), 1182–1188.
   PubMed Web of Science ®Google Scholar
• Shah, P.P., et al., 2009. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutation research, 670(1–2), 74–78.
   PubMed Web of Science ®Google Scholar
• Sharma, A., et al., 2012. Ethanol induced induction of cytochrome P450 2E1 and activation of mitogen activated protein kinases in peripheral blood lymphocytes. Xenobiotica, 42(4), 317–326.
   PubMed Web of Science ®Google Scholar
• Sharma, A., et al., 2013. Cytochrome P450 2A isoenzymes in freshly prepared blood lymphocytes isolated from rats and validation as a biomarker for clinical studies in humans. Xenobiotica, 43(4), 311–319.
   PubMed Web of Science ®Google Scholar
• Shatalova, E.G., et al., 2011. Estrogen and cytochrome P450 1B1 contribute to both early-and late-stage head and neck carcinogenesis. Cancer prevention research, 4(1), 107–115.
   PubMed Web of Science ®Google Scholar
• Siest, G., et al., 2007. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug metabolism and disposition, 36(1), 182–189.
   PubMed Web of Science ®Google Scholar
• Singh, A.P., et al., 2009. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk. Cancer investigation, 27(8), 869–876.
   PubMed Web of Science ®Google Scholar
• Smith, A., Teknos, T.N., and Pan, Q., 2013. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral oncology, 49(4), 287–292.
   PubMed Web of Science ®Google Scholar
• Spivack, S.D., et al., 2003. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clinical cancer research, 9, 6002–6011.
   PubMed Web of Science ®Google Scholar
• Sundberg, K., et al., 1998. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19(3), 433–436.
   PubMed Web of Science ®Google Scholar
• Sutter, C.H., et al., 2002. Genotyping human cytochrome: P450 1B1 variants. Methods in enzymology, 357, 53–58.
   PubMed Web of Science ®Google Scholar
• Vidal, F., et al., 2004. Genetic polymorphisms of ADH 2, ADH 3, CYP 450 2E1 Dra-I and Pst-I, and ALDH 2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. Journal of hepatology, 41(5), 744–750.
   PubMed Web of Science ®Google Scholar
• Wiencke, J.K., 2002. DNA adduct burden and tobacco carcinogenesis. Oncogene, 21(48), 7376.
   PubMed Web of Science ®Google Scholar
• Wu, M.-F., et al., 2004. Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicology letters, 150(2), 211–219.
   PubMed Web of Science ®Google Scholar
• Wu, M.-T., et al., 1998. Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers. Cancer epidemiology biomarkers & prevention, 7, 823–829.
   PubMed Web of Science ®Google Scholar
• Yamazaki, H., et al., 1999. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Archives of toxicology, 73(2), 65–70.
   PubMed Web of Science ®Google Scholar
• Yang, B., et al., 2016. Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: a meta-analysis. Oncotarget, 7(30), 47265.
   PubMedGoogle Scholar
• Zieker, D., et al., 2005. cDNA microarray analysis reveals novel candidate genes expressed in human peripheral blood following exhaustive exercise. Physiological genomics, 23(3), 287–294.
   PubMed Web of Science ®Google Scholar